X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217965
https://www.strides.com/pdf/pressrelease/2024/StridesSEIntimation_Mar05_24.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218075
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216252
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203934
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216252
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217995
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-17-2023-88450.pdf
https://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/granules-india-receives-usfda-approval-for-generic-gabapentin-tablets/articleshow/99091739.cms?utm_source=contentofinterest&utm_medium=text&utm_campaign=cppst
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-8-2023-15780.pdf
https://health.economictimes.indiatimes.com/news/pharma/usfda-approves-zydus-gabapentin-tablets/98087826
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203934
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=216492
https://www.upi.com/Health_News/2022/08/08/gabapentin-opioid-overdose-deaths/6501659562315/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214957
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-24-2021-1616562985.pdf
https://www.biospectrumasia.com/news/25/16985/sihuan-pharma-obtains-production-approval-for-gabapentin-capsules.html
https://www.biospectrumasia.com/news/25/16985/sihuan-pharma-obtains-production-approval-for-gabapentin-capsules.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213603
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-may-27-2020-1590562594.pdf
https://www.fda.gov/drugs/drug-safety-and-availability/fda-warns-about-serious-breathing-problems-seizure-and-nerve-pain-medicines-gabapentin-neurontin
https://www.globenewswire.com/news-release/2019/12/12/1959802/0/en/Assertio-Therapeutics-Announces-Sale-of-Gralise-for-Total-Transaction-Value-of-127-5-Million.html
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-27-2019-1553661457.pdf
https://www.fda.gov/Drugs/NewsEvents/ucm625919.htm?utm_campaign=CDER%20New%2011%2F16&utm_medium=email&utm_source=Eloqua&elqTrackId=35c0d0eb30a6463eaa1cf3ef7ddaa25f&elq=515a8ffae2314fe199840fb652663aa6&elqaid=5917&elqat=1&elqCampaignId=4772
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211314
https://www.prnewswire.com/news-releases/quest-diagnostics-health-trends-study-finds-drug-misuse-rates-remain-constant-at-high-levels-and-dangerous-opioid-related-drug-combining-is-prevalent-300707548.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209306
https://www.medpagetoday.com/neurology/painmanagement/74655
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209156
http://www.pharmatimes.com/news/nhs_could_claw_back_502m_if_lyrica_ruling_upheld,_study_finds_1223986
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-january-17-2018-1516166737.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207057
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=091008
https://www.pharmacompass.com/pdf/news/top-selling-top-prescribed-drugs-for-2016-1507784462.pdf
https://www.painnewsnetwork.org/stories/2017/8/15/lyrica-and-neurontin-face-more-scrutiny
http://www.nejm.org/doi/full/10.1056/NEJMp1704633?rss=searchAndBrowse
https://www.statnews.com/2017/07/06/gabapentin-opioid-abuse/
http://www.pmlive.com/pharma_news/daiichi_drug_hits_mark_in_shingles_pain,_but_misses_in_other_indications_1197434
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207099
http://www.in-pharmatechnologist.com/Ingredients/Misbranded-epilepsy-drug-API-lands-FDA-warning-for-Chinese-firm
http://www.medicaldaily.com/gabapentin-side-effects-dangers-label-prescriptions-surprising-side-effects-403998?
http://www.prnewswire.com/news-releases/study-finds-one-in-five-pain-or-rehab-patients-taking-the-medication-gabapentin-without-prescription-300308428.html
http://www.fdalawblog.net/fda_law_blog_hyman_phelps/2016/04/a-hole-in-one-eagle-sues-fda-over-bendeka-orphan-drug-exclusivity-in-depomed-like-lawsuit.html
http://www.prnewswire.com/news-releases/breckenridge-announces-approval-for-gabapentin-oral-solution-300238032.html
https://www.pharmacompass.com/pdf/news/tris-pharmas-generic-gabapentin-approved-in-us-as-an-antiepileptic-drug-1458213530.pdf
https://www.pharmacompass.com/pdf/news/sciegen-pharms-generic-gabapentin-approved-in-us-to-treat-epilepsy-neuropathic-pain-and-hot-flashes-1456221634.pdf
https://www.pharmacompass.com/pdf/news/sciegen-pharms-generic-gabapentin-approved-in-us-as-an-antiepileptic-drug-1455271656.pdf
http://www.forbes.com/sites/erikakelton/2015/12/03/pfizer-allergan-merger-raises-concerns-that-fraud-is-part-of-corporate-dna/?ss=pharma-healthcare
http://www.prnewswire.com/news-releases/depomed-issues-statement-on-horizon-pharma-plcs-unsolicited-exchange-offer-300138965.html
Market Place
Share 
